Oppenheimer Asset Management Inc. Organon & Co. Transaction History

Oppenheimer Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 06, 2023	SELL	$23.31 - $28.61 $13,962 - $17,137	-599 Reduced 6.93%	8,040 $224,000
Q3 2022 Nov 14, 2022	SELL	$23.4 - $34.25 $3.99 Million - $5.83 Million	-170,300 Reduced 95.17%	8,639 $201,000
Q2 2022 Aug 08, 2022	SELL	$31.66 - $38.9 $103,781 - $127,514	-3,278 Reduced 1.8%	178,939 $6.04 Million
Q1 2022 May 12, 2022	BUY	$30.45 - $39.36 $489,209 - $632,357	16,066 Added 9.67%	182,217 $6.36 Million
Q4 2021 Feb 02, 2022	SELL	$28.67 - $37.13 $581,972 - $753,701	-20,299 Reduced 10.89%	166,151 $5.06 Million
Q3 2021 Nov 12, 2021	BUY	$28.63 - $35.64 $3.45 Million - $4.3 Million	120,650 Added 183.36%	186,450 $6.11 Million
Q2 2021 Aug 03, 2021	BUY	$28.45 - $38.0 $1.87 Million - $2.5 Million	65,800 New	65,800 $1.99 Million

813

201M

1.53M

1.07M

Ticker OGN
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 254,330,000
Market Cap $3.9B
Description
Organon & Co., a health care company, develops and delivers health solutions through a portfolio of prescription therapies in the United States and internationally. Its women's health portfolio comprises contraception and fertility brands, such as Nexplanon/Implanon, a long-acting reversible contraceptive. The company's biosimilars portfolio...

Get notified when there are updates to the investment portfolio of Oppenheimer Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Oppenheimer Asset Management Inc. with notifications on news.